| Lingua originale | English |
|---|---|
| pagine (da-a) | 2505-2525 |
| Numero di pagine | 21 |
| Rivista | Inflammatory Bowel Diseases |
| Volume | 12 |
| Stato di pubblicazione | Published - 2011 |
Cita questo
Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit. / Cottone, Mario.
In: Inflammatory Bowel Diseases, Vol. 12, 2011, pag. 2505-2525.Risultato della ricerca: Article
Cottone, M 2011, 'Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit', Inflammatory Bowel Diseases, vol. 12, pagg. 2505-2525.
@article{b16c7d8f690241308db7cba28977d0d0,
title = "Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit",
keywords = "Prognostic factors for clinical benefit",
author = "Mario Cottone",
year = "2011",
language = "English",
volume = "12",
pages = "2505--2525",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
}
TY - JOUR
T1 - Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit
AU - Cottone, Mario
PY - 2011
Y1 - 2011
KW - Prognostic factors for clinical benefit
UR - http://hdl.handle.net/10447/60574
M3 - Article
VL - 12
SP - 2505
EP - 2525
JO - Inflammatory Bowel Diseases
JF - Inflammatory Bowel Diseases
SN - 1078-0998
ER -